Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

SLRX Company Profile and Key Details

NASDAQ : SLRX

Salarius Pharmaceuticals

$0.78
-0.2226-22.27%
Open: 1:39 PM
64.8
BESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

Price Chart

Stock Price Today

Salarius Pharmaceuticals, Inc. (SLRX) stock declined over -22.27%, trading at $0.78 on NASDAQ, down from the previous close of $1.00. The stock opened at $0.89, fluctuating between $0.73 and $0.92 in the recent session.

Stock Snapshot

0.9996
Prev. Close
1.65M
Market Cap
0.7254
Day Low
-0.22
P/E Ratio
-3.55
EPS (TTM)
-3.26
Cash Flow per Share
0.89
Open
2.13M
Number of Shares
0.92
Day High
99.32%
Free Float in %
1.34
Book Value
4.82M
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Jul 29, 20251.562.310.971.0092.02M
Jul 28, 20250.800.800.720.74153.44K
Jul 25, 20250.750.780.710.75251.59K
Jul 24, 20250.690.770.680.75365.01K
Jul 23, 20250.690.730.680.7095.16K
Jul 22, 20250.750.750.670.71133.5K
Jul 21, 20250.650.750.620.73262.35K
Jul 18, 20250.610.650.610.61118.39K
Jul 17, 20250.620.660.600.61238.28K
Jul 16, 20250.700.700.610.63317.99K
Jul 15, 20250.660.690.650.68172.85K
Jul 14, 20250.710.720.640.68452.37K
Jul 11, 20250.770.810.670.75187.44K
Jul 10, 20250.890.890.710.78148.3K
Jul 09, 20250.860.890.660.761.08M
Jul 08, 20250.800.850.780.7995.61K
Jul 07, 20250.870.870.750.8391.85K
Jul 03, 20250.880.900.860.8945.55K
Jul 02, 20250.870.900.870.9041.1K
Jul 01, 20250.870.930.860.8859.82K

Contact Details

Houston, TX 77021

United States

https://www.salariuspharma.com832 834 6992

About Company

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds; HLB Life Sciences to develop, produce, manufacture, use, and sell the drug in South Korea; and Cancer Prevention and Research Institute of Texas for product development activities, as well as a research partnership with the Cancer Epigenetics Institute at Fox Chase Cancer Center to identify new indications and biomarkers for SP-2577. The company is headquartered in Houston, Texas.

Company Information

Employees2
Beta0.38
Sales or Revenue$0.00
5Y Sales Change%-1%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Salarius Pharmaceuticals, Inc. (SLRX) stock price?
Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) stock price is $0.78 in the last trading session. During the trading session, SLRX stock reached the peak price of $0.92 while $0.73 was the lowest point it dropped to. The percentage change in SLRX stock occurred in the recent session was -22.27% while the dollar amount for the price change in SLRX stock was -$0.22.
SLRX's industry and sector of operation?
The NASDAQ listed SLRX is part of Biotechnology industry that operates in the broader Healthcare sector. Salarius Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of SLRX?
Mr. Mark J. Rosenblum CPA
Executive Vice President of Fin. & Chief Financial Officer
Mr. David J. Arthur M.B.A.
Chief Executive Officer, Pres & Director
Dr. Nadeem Q. Mirza M.D., M.P.H.
Senior Vice President of Clinical Devel.
Dr. Daniela Y. Santiesteban
Director of Targeted Protein Degradation Program
How SLRX did perform over past 52-week?
SLRX's closing price is 121.15% higher than its 52-week low of $0.45 where as its distance from 52-week high of $7.20 is -86.12%.
How many employees does SLRX have?
Number of SLRX employees currently stands at 2.
Link for SLRX official website?
Official Website of SLRX is: https://www.salariuspharma.com
How do I contact SLRX?
SLRX could be contacted at phone 832 834 6992 and can also be accessed through its website. SLRX operates from 2450 Holcombe Boulevard, Houston, TX 77021, United States.
How many shares of SLRX are traded daily?
SLRX stock volume for the day was 4.82M shares. The average number of SLRX shares traded daily for last 3 months was 2.92M.
What is the market cap of SLRX currently?
The market value of SLRX currently stands at $1.65M with its latest stock price at $0.78 and 2.13M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings Calendar
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph